Table 2 Hypermethylation of the POU2F3 promoter in cervical cancer cell lines and cervical tissue
From: Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer
Samples | Tumor classification | Methylation | ||
---|---|---|---|---|
 |  | Positive | Negative | Frequency of methylation (%) |
Cervical cancers | Â | 18 | 28 | 18/46 (39%) |
 | Histology a |  |  |  |
 |  Adenocarcinoma | 1 | 4 |  |
 |  Adenosquamous | 4 | 5 |  |
 |  Squamous | 13 | 19 |  |
 | HPV type a |  |  |  |
 |  HPV16 | 7 | 11 |  |
 |  HPV18 | 4 | 9 |  |
 |  Other | 2 | 5 |  |
 |  Multiple | 5 | 3 |  |
 | Stage a |  |  |  |
 |  I | 16 | 25 |  |
 |  II | 2 | 3 |  |
 | Lymph node metastasis a |  |  |  |
 |  Positive | 3 | 6 |  |
 |  Negative | 10 | 17 |  |
 |  ND | 5 | 5 |  |
CC cell lines | Â | 6 | 5 | 6/11 (54.5%) |
Normal cervical epithelium | Â | 0 | 7 | 0/7 (0%) |